Applicant, as named in the Orange Book

Zydus Lifesciences

Next listed expiry: Zituvio on 25 Feb 2035. 1 products with live protection, 2 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Zituvio · 3 strengths sitagliptin	sitagliptin	211566	25 Feb 2035	patent

Products without listed protection (2)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Zituvimet · 2 strengths metformin hydrochloride; sitagliptin	metformin hydrochloride; sitagliptin	216743	open now	no listed protection
Zituvimet Xr · 3 strengths metformin hydrochloride; sitagliptin	metformin hydrochloride; sitagliptin	216778	open now	no listed protection